Literature DB >> 17085805

Generation of transgenic mice for cardiovascular research.

Xiao-Li Tian1, Qing K Wang.   

Abstract

The transgenic mouse technology is a powerful tool that can be used for creating animal models for cardiovascular disease to identify molecular pathogenic mechanisms and for identifying the physiological functions of a novel gene. A transgenic animal can be generated by several methods, which include microinjection of a DNA fragment into the pronucleus, embryonic stem cell manipulation and injection, sperm-mediated transgenesis, and viral infection of preimplanted embryos. The microinjection method is one of the most widely used approaches. This method involves four steps: (1) collection of fertilized eggs from the superovulated female, (2) injection of DNA into the pronucleus of fertilized eggs, (3) transfer of the injected eggs back into the oviduct of a pseudopregnant foster recipient, allowing the eggs to develop into pups, and (4) identification of the transgenic founder and establishment of transgenic lines through further breeding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17085805     DOI: 10.1385/1-59745-213-0:69

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  9 in total

1.  Exon 47 skipping of fibrillin-1 leads preferentially to cardiovascular defects in patients with thoracic aortic aneurysms and dissections.

Authors:  Wen-Jing Wang; Peili Han; Jun Zheng; Fang-Yuan Hu; Yun Zhu; Jin-Sheng Xie; Jian Guo; Zhe Zhang; Jie Dong; Gu-Yan Zheng; Huiqing Cao; Tian-Shu Liu; Qinglin Fu; Lizhong Sun; Bi-Bo Yang; Xiao-Li Tian
Journal:  J Mol Med (Berl)       Date:  2012-07-08       Impact factor: 4.599

2.  Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.

Authors:  Teng Zhang; Sandro L Yong; Xiao-Li Tian; Qing K Wang
Journal:  Biochem Biophys Res Commun       Date:  2007-02-07       Impact factor: 3.575

3.  Generation of Transgenic Mice Expressing Cytosolic and Targeted FRET Biosensors for cAMP and cGMP.

Authors:  Roberta Kurelić; Viacheslav O Nikolaev
Journal:  Methods Mol Biol       Date:  2022

4.  Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations.

Authors:  Yang Li; Wen-Jing Wang; Huiqing Cao; Jiehua Lu; Chong Wu; Fang-Yuan Hu; Jian Guo; Ling Zhao; Fan Yang; Yi-Xin Zhang; Wei Li; Gu-Yan Zheng; Hanbin Cui; Xiaomin Chen; Zhiming Zhu; Hongbo He; Birong Dong; Xianming Mo; Yi Zeng; Xiao-Li Tian
Journal:  Hum Mol Genet       Date:  2009-09-29       Impact factor: 6.150

5.  The Functional Polymorphism R129W in the BVES Gene Is Associated with Sporadic Tetralogy of Fallot in the Han Chinese Population.

Authors:  Yan Shi; Yongqing Li; Yuequn Wang; Jian Zhuang; Heng Wang; Min Hu; Xiaoyang Mo; Shusheng Yue; Yu Chen; Xiongwei Fan; Jimei Chen; Wanwan Cai; Xiaolan Zhu; Yongqi Wan; Ying Zhong; Xiangli Ye; Fang Li; Zuoqiong Zhou; Guo Dai; Rong Luo; Karen Ocorr; Zhigang Jiang; Xiaoping Li; Ping Zhu; Xiushan Wu; Wuzhou Yuan
Journal:  Genet Test Mol Biomarkers       Date:  2019-08-06

6.  Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese.

Authors:  Ying Zhao; Yanbo Yu; Xiaoli Tian; Xi Yang; Xueqi Li; Feng Jiang; Yundai Chen; Maowei Shi
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

7.  Association study to evaluate TFPI gene in CAD in Han Chinese.

Authors:  Ying Zhao; Yanbo Yu; Maowei Shi; Xi Yang; Xueqi Li; Feng Jiang; Yundai Chen; Xiaoli Tian
Journal:  BMC Cardiovasc Disord       Date:  2017-07-17       Impact factor: 2.298

8.  Mutational screening of affected cardiac tissues and peripheral blood cells identified novel somatic mutations in GATA4 in patients with ventricular septal defect.

Authors:  Chunyan Cheng; Yuan Lin; Fan Yang; Wenjing Wang; Chong Wu; Jingli Qin; Xiuqin Shao; Lei Zhou
Journal:  J Biomed Res       Date:  2011-11

9.  NEXN is a novel susceptibility gene for coronary artery disease in Han Chinese.

Authors:  Chong Wu; Han Yan; Jingzhi Sun; Fan Yang; Chun Song; Feng Jiang; Yang Li; Jie Dong; Gu-Yan Zheng; Xiao-Li Tian; Huiqing Cao
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.